About the Authors
- Carlos Zgheib
-
Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
- Mazen Kurdi
-
Affiliation Department of Chemistry and Biochemistry, Faculty of Sciences, Lebanese University, Rafic Hariri Educational Campus, Hadath, Lebanon
- Fouad A. Zouein
-
Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
- Barak W. Gunter
-
Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
- Brian A. Stanley
-
Affiliation Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America
- Joe Zgheib
-
Affiliation Department of Medicine, Division of Cardiology, Centre Hospitalier Universitaire de Nancy, Brabois, France
- Damian G. Romero
-
Affiliation Department of Biochemistry, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
- S. Bruce King
-
Affiliation Department of Chemistry, Wake Forest University, Winston-Salem, North Carolina, United States of America
- Nazareno Paolocci
-
Affiliations Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Clinical Medicine Department, Section of General Pathology, University of Perugia, Perugia, Italy
- George W. Booz
-
* E-mail: gbooz@umc.edu
Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
Competing Interests
The authors have read the journal’s policy and have the following conflict: Nazareno Paolocci is a founder and stock holder of Cardioxyl Pharmaceuticals Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CZ FAZ MK GWB. Performed the experiments: CZ FAZ MK BWG BAS GWB. Analyzed the data: CZ FAZ MK BWG GWB. Contributed reagents/materials/analysis tools: JZ SBK NP DGR GWB. Wrote the paper: CZ MK FAZ JZ NP BAS GWB.